Plasma Prostaglandin E2 Concentrations after Single Dose Administration of Ketorofac Tromethamine (Toradol) in Dogs

Canadian Journal of Veterinary Research

Volumn 62, Issue 3, 1998, Pages 237-240

  Pasloske, Kirby ^a,b   Burger, John ^a   Conlon, Peter ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b Merck and Company Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; KETOROLAC; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; DRUG DERIVATIVE; TOLMETIN; TROMETAMOL;

ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOGS; FEMALE; KETOROLAC TROMETHAMINE; MALE; TIME FACTORS; TOLMETIN; TROMETHAMINE;

EID: 0031595477     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. HIGGINS AJ. The biology, pathophysiology and control of eicosanoids in inflammation. J Vet Pharmacol Ther 1985; 8: 1-18.
2. DAVIES P. MacINTYRE DE. Prostaglandins in inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York: New York Press. 1992: 123-138.
3. WEISSMAN G, DUKOR P, ZURIER RB. Effect of cyclic AMP on release of lysosoraal enzymes from phagocytes. Nature 1971; 231: 131-134.
4. TATESON JE, MONCADA S, VANE JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977; 13: 389-399.
5. WEKSLER BB, KNAPP JM, JAFFE EA. Prostacyclin synthesized by cultured endothelial cells modulates polymorphonuclear leukocyte function (abstr). Blood 1977; 50 (suppl. 1): 287.
6. 1, on adjuvant arthritis. Nature (London) 1971; 234: 304-306.
7. ZURIER RB, DAMJANOV L, MILLER PL, BIEWER BF. Prostaglandin E, treatment of NZB/NZW F, hybrid mice. Arthritis Rheum 1977; 20: 1449-1456.
8. KUNKEL SL, THRALL RS, KUNKEL RG, McCORMICK JR, WARD RA, ZURIER RB. Suppression of immune complex vasculitis in rats by prostaglandin. J Clin Invest 1979; 64: 1525-1527.
9. ROBERT A. Cytoprotection by prostaalandins. Gastroenterolosy 1979; 77: 761-777.
10. HENRICH WL, BERL T, McDONALD KM, ANDERSON RJ, SCHRIER RW. Angiotensin II. renal nerves and prostaglandins in renal hemodynamics during hemorrhage. Am J Physiol 1978; 235: F46-F51.
11. VANE JR. Towards a better aspirin. Nature 1994; 367: 215-216.
12. ERNSTAD BL, NEUMAYER LA. Massive gastrointestinal bleeding associated with ketorolac administration. J Pharm Pract 1992: 5: xi-xii.
13. ESTES LL, FUHS DW, HEATON AH, BUTWINICK CS. Gastric ulcer perforation associated with the use of injectable ketorolac. Ann Pharmacother 1993; 27: 42-43.
14. WOLFE PA, POLLHAMUS CD, KUBIK C, ROBINSON AB, CLEMENT DJ. Giant duodenal ulcers associated with the postoperative use of ketorolac: Report of three cases. Am J Gastroenterol 1994; 89. 1110-1111.
15. BORAS-UBER LA, BRACKETT NC. Ketorolac-induced acute renal failure. Am J Med 1992; 92: 450-452.
16. SCHOCH PH, RANNO A, NORTH DS. Acute renal failure in an elderly woman following intramuscular ketorolac administration. Ann Pharmacother 1992; 26: 1223-1226.
17. SMITH K, HALLIWELL RMT, LAWRENCE S, KLINEBERG PL, O'CONNELL P. Acute renal failure associated with intramuscular ketorolac. Anaesth Intensive Care 1993; 21: 700-703.
18. MATHEWS K, PALEY DM, FOSTER RA, VALLIANT AE, YOUNG SS. A comparison of ketorolac with flunixin, butorphanol. and oxymorphone in controlling postoperative pain in doss. Can Vet J 1996; 37: 557-567.
19. MATHEWS K. Nonsteroidal antiinflammatory analgesics to manage acute pain in dogs and cats. Compend Contin Educ Pract Vet 1996; 37: 557-567.
20. OLFERT ED, CROSS BM, McWILLIAM, eds. Guide to the Care and Use of Experimental Animals, Volumes 1 and 2, 2nd ed. Ottawa: Canadian Council on Animal Care. 1993: 202.
21. BIOTEK APPLICATION SOFTWARE. Highland Park. Winooski. Vermont, USA. 1987.
22. SAS FOR WINDOWS (6.12). SAS Institute Inc., Cary, North Carolina, USA, 1996.
23. KNAPP DW, RICHARDSON RC, CHAN TCK, BOTTOMS GD, WIDMER WR, DeNICOLA DB, TECLAW R, BONNEY PL, KUCZEK T. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994; 8: 273-278.
24. KURODA T, KAJIKAWA S, HANAZAKI K, HORIGOME N, SODEYAMA H, HORIUCHI A, IWATSUKI K, CHIBA S, HOMMA T, LIDA F. Enhanced production of endogenous prostaglandin in obstructive jaundiced pancreas in dogs. Gastroenterology 1990; 98: 1292-1298.
25. LECOMPTE M, LANEUVILLE O, JI C, DEWITT DL, SMITH WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclo-oxygenase 2) by aspirin. J Biol Chem 1994; 269: 13207-13215.
26. PALLAPIES D, PESKAR BA, BRUNE K, GEISSLINGER G. Effects of platelet function and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses. Br J Clin Pharmacol 1994; 37: 335-339.